Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1.

Current gene therapy

Volumn 2, Issue 2, 2002, Pages 145-159

  Owens, Roland A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; REP PROTEINS, ADENO ASSOCIATED VIRUS 2; REP PROTEINS, ADENO-ASSOCIATED VIRUS 2; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL; BIOLOGICAL MODEL; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLASMID; REVIEW; VIRUS GENOME;

ANIMALS; BASE SEQUENCE; DEPENDOVIRUS; DNA-BINDING PROTEINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOME, VIRAL; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PLASMIDS; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

EID: 0036559620     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523024605627     Document Type: Review

References (140)